{"id":17813,"date":"2014-03-24T10:30:00","date_gmt":"2014-03-24T09:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/corte-suprema-arkansas-annulla-multa-12-mld-a-jj\/"},"modified":"2014-03-24T10:30:00","modified_gmt":"2014-03-24T09:30:00","slug":"corte-suprema-arkansas-annulla-multa-12-mld-a-jj","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/corte-suprema-arkansas-annulla-multa-12-mld-a-jj\/","title":{"rendered":"Arkansas Supreme Court Overturns J&amp;J&#039;s $1.2 Billion Fine"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">The US state Supreme Court of Arkansas overturned a $1.2 billion fine imposed two years ago on Johnson &amp; Johnson for allegedly unlawful marketing of its antipsychotic drug Risperdal (risperidone).<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">The fine was handed down in April 2012 after the Janssen Pharmaceutical Unit was guilty of &quot;false and deceptive acts&quot; by sending letters promoting the product to more than 6,000 doctors in the US, according to a Little Rock jury. US state in 2003, stating that Risperdal had a superior safety profile compared to competing products. <\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">The Arkansas Supreme Court rejected that decision, because the wrong law was invoked in J&amp;J&#039;s suit, pertaining to healthcare facilities and not pharmaceutical companies. The 181 million dollars to cover the legal costs that the company would have had to bear were also suspended.<\/p>\n<p><\/font><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><i><span style=\"line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; color: #212120; font-size: 9pt; mso-bidi-font-weight: bold\">Monday, March 24, 2014 \u2013<\/span><\/i><i><span style=\"line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; color: #c00000; font-size: 9pt; mso-bidi-font-weight: bold\"> <\/span><\/i><span style=\"line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; color: #c00000; font-size: 9pt; mso-bidi-font-style: italic; mso-bidi-font-weight: bold\">Pharma<i>Kronos<\/i><\/span><\/p>\n<p style=\"text-align: left\">&nbsp;<\/p>\n<p style=\"text-align: left\">&nbsp;<\/p>\n<p style=\"text-align: left\">&nbsp;<\/p>\n<p style=\"text-align: left\">&nbsp;<\/p>\n<p style=\"text-align: left\">&nbsp; <img","protected":false},"excerpt":{"rendered":"<p>La Corte suprema dello Stato americano dell&#8217;Arkansas ha annullato una multa di 1,2 miliardi di dollari imposta due anni fa a Johnson &amp; Johnson per presunto marketing illecito del suo farmaco antipsicotico Risperdal (risperidone). La sanzione era stata inflitta nell&#8217;aprile 2012 dopo che, secondo una giuria di Little Rock, l&#8217;unit&agrave; farmaceutica Janssen si era resa &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-17813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=17813"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/17813\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=17813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=17813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=17813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}